Stay updated on CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.

Latest updates to the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
- Check27 days agoChange DetectedThe web page has undergone significant updates, including the replacement of the drug name from PLX9486 to CGT9486, and the addition of detailed dosing information and study protocols for the CGT9486 trials. Additionally, the results reporting dates have been updated to reflect new timelines.SummaryDifference100%
- Check34 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
- Check41 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check55 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check63 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
Stay in the know with updates to CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CGT9486 Alone and With PLX3397 or Sunitinib in Solid Tumors Clinical Trial page.